GENTRONIX
gentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries. Their primary focus is on providing better hazard identification assays for genotoxicity through the use of their patented human cell GADD45a reporter assays GreenScreen® HC and BlueScreen HC.
GENTRONIX
Industry:
Biotechnology Chemical Cosmetics
Founded:
1999-01-01
Address:
Manchester, Manchester, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gentronix.co.uk
Total Employee:
11+
Status:
Active
Contact:
44-(0)-161-603-7676
Total Funding:
5.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
SiSaf
Delivering on the promise of RNA therapeutics
Current Employees Featured
Richard Walmsley Founder, Board Member and Chief Scientific Officer @ Gentronix
Founder, Board Member and Chief Scientific Officer
1999-07-01
John Nicholson Chairman and CEO @ Gentronix
Chairman and CEO
2005-01-01
Founder
Investors List
Mercia Fund Managers
Mercia Fund Managers investment in Venture Round - Gentronix
Mercia Asset Management
Mercia Asset Management investment in Venture Round - Gentronix
NVM Private Equity
NVM Private Equity investment in Venture Round - Gentronix
YFM Equity Partners
YFM Equity Partners investment in Venture Round - Gentronix
Manchester Technology Fund
Manchester Technology Fund investment in Venture Round - Gentronix
Official Site Inspections
http://www.gentronix.co.uk
- Host name: 343934.cloudwaysapps.com
- IP address: 134.209.182.81
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Gentronix"
Scantox Acquires Gentronix | Leader in Genetic …
Sep 9, 2024 Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization (“CRO”). Gentronix, now integrated into …See details»
Scantox Group acquires Gentronix - Scantox
Sep 9, 2024 As an organization we look forward to collaborating with our new colleagues and continuing to support the delivery of world-leading contract research services to our customers. There is a strong strategic rationale in …See details»
Gentronix - Crunchbase Company Profile & Funding
Organization. Gentronix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Gentronix provides …See details»
Gentronix Wins King's Award for Global Growth
May 7, 2024 Gentronix, a UK-based Contract Research Organisation (CRO) specializing in predictive toxicology, has been honoured with the King’s Award for Enterprise due to its remarkable international growth. Over the past three …See details»
Scantox Group acquires Gentronix, a world leader in genetic …
Sep 9, 2024 Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization …See details»
Scantox Group Acquires Gentronix, a World leader in Genetic …
Sep 10, 2024 Further, Gentronix has expertise and services within ocular and skin toxicology endpoints. Founded in 1999 by Prof. Richard Walmsely, Gentronix is located within the North …See details»
Scantox acquires Gentronix, a UK based genetic toxicology CRO
Scantox, together with its majority owner Impilo, has acquired Gentronix Ltd, a UK based GLP-compliant genetic toxicology Contract Research Organization (“CRO”). Gentronix, now …See details»
Scantox Group Acquires UK-Based Gentronix to Expand Genetic …
Sep 9, 2024 Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization …See details»
Sale of Gentronix represents 4.5x return for Northern …
Sep 9, 2024 Gentronix – the UK-based contract research organisation (CRO) that is a world leader in genetic toxicology – has been acquired by Scantox Group of Denmark for an undisclosed sum.. The deal provides an exit for Mercia …See details»
Gentronix Company Profile - Office Locations, Competitors, …
Gentronix has 5 employees at their 1 location and $5.05 m in total funding,. See insights on Gentronix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Gentronix - The Org
Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors. Website. gentronix.co.uk. Headquarters. Manchester, United Kingdom. Industries. Beauty & Cosmetics, …See details»
Life sciences firm Gentronix set for ‘fantastic next step’ after it is ...
Sep 9, 2024 Fast-growing life sciences business Gentronix has been acquired by Danish business Scantox Group in what bosses say is a “fantastic next step” for the company and its 70 staff. Alderley Park-based Gentronix offers genetic toxicology solutions to the global pharmaceutical, biotech and agrichemical industries.See details»
Gentronix: 25 Years of Expertise in Predictive Toxicology
For 25 years, Gentronix Ltd has provided predictive toxicology solutions to global chemical industries; enabling our clients to optimise their development programmes via early …See details»
Gentronix 2025 Company Profile: Valuation, Investors ... - PitchBook
Gentronix General Information Description. Operator of a specialist contract research organization (CRO) and provides genetic toxicology services to the global pharma, biotech, and agrichem …See details»
Gentronix, Part of Scantox Group Company Overview, Contact …
Nov 15, 2021 Gentronix - the UK-based contract research organisation (CRO) that is a leader in the field of genetic toxicology - has raised £700,000 in a funding round led by existing investor …See details»
Gentronix recognised with King’s award after record international …
7 May 2024 - UK-based Contract Research Organisation (CRO) Gentronix – a leading specialist toxicology firm based at Alderley Park – has been awarded the King’s Award for Enterprise …See details»
Gentronix recognised with King’s award after record ... - Mercia
May 7, 2024 UK-based Contract Research Organisation (CRO) Gentronix – a leading specialist toxicology firm based at Alderley Park – has been awarded the King’s Award for Enterprise after achieving a triple-figure revenue growth following rapid expansion in international markets. Gentronix recorded total growth of 239% in overseas earnings over the past three years, with …See details»
Gentronix set to double in size after new funding round
Nov 16, 2021 Gentronix – the UK-based contract research organisation (CRO) that is a leader in the field of genetic toxicology – has raised £700,000 in a funding round led by existing investor …See details»
Gentronix Acquired by Scantox Group in Strategic CRO Expansion
Sep 10, 2024 Gentronix, a contract research organisation (CRO) based in the UK and focused on genetic toxicology, has been acquired by Denmark’s Scantox Group for an undisclosed sum. The deal marks a significant exit for Mercia Ventures’ Northern Venture Capital Trusts (VCTs), which sold their stake in Gentronix for £14.8 million, representing a 4.5x return on investment.See details»